Dow Up 0.19% Nasdaq Up 0.56%

Janus Global Life Sciences T (JAGLX)

55.41 Up 0.11(0.20%) Nov 20
Prev Close:55.30
YTD Return*:27.37%
Net Assets*:2.87B
Yield*:N/A

* As of 31-Oct-14

Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for JAGLX at this time.

Top Holdings

Symbol% AssetsYTD Return %
GILD3.3646.44
VRX.TO2.6813.16
CELG2.5727.14
MNK2.5678.78
JNJ2.5219.58

Fund Basics

Morningstar Overall Rating:
Total Assets:2.87B
Category:Health
Annual Report Expense Ratio (net):0.94%

Performance & Risk

YTD Return:27.37%
5y Avg Return:25.72%
Rank in Category (ytd):19
% Rank in Category (ytd):15.08%
Beta (3y):0.68
Morningstar Risk Rating:3

Fund Summary

The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback